NLS Collaboration

BioLamina with partners in the innovation milieu IndiCell receive funding to establish and propel individualized cell therapy treatments in Sweden. The funded project focuses on an autologous therapy model, in which skin cells are harvested from the patients themselves, then carefully reprogrammed into induced pluripotent stem (iPS) cells in the laboratory, and finally returned to […]

This event will offer a week of biotech, pharma and finance, including several very interesting on demand sessions. The digital event, October 25-28, will include one-to-one meetings, company presentations, company showcases and interesting keynotes and panels. Global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic […]

Ascelia Pharma has signed an agreement with Taiho Oncology, a subsidiary of Taiho Pharmaceutical. The collaboration concerns an upcoming global Phase 2 clinical study in gastric cancer. In this all-oral combination study, Ascelia Pharma’s irinotecan chemotherapy tablet Oncoral (ASC-201) will be evaluated in combination with Taiho Oncology’s LONSURF (trifluridine and tipiracil) film-coated tablets for oral […]

Bioneer has announced a strategic collaboration with the National Biologics Facility (NBF) to commercialize their combined CRO services for mammalian expression of recombinant proteins. The entity, previously named CHO CORE, is one of the largest academic groups in the world working on Chinese Hamster Ovary cell (CHO) modelling and mechanisms. Funded by the Novo Nordisk […]

Our latest issue, No 03 2021, is out – sign up for a subscription today and stay updated on the Nordic life science industry’s latest progress and challenges. The Nordic life science industry has not only survived, but managed to grow and develop during the pandemic. Read more about how the past 1.5 years have […]

Alligator Bioscience and Scandion Oncology have announced the conclusion of their collaboration with a very positive outcome. The purpose of the collaboration was to explore the anti-tumor efficacy of the CD40 antibody mitazalimab in chemotherapy-resistant preclinical tumor models as an addition to chemotherapy (FOLFIRINOX) combined with SCO-101. The hypothesis that was tested was to see […]